Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Eur J Med Chem
2020 May 15;194:112261. doi: 10.1016/j.ejmech.2020.112261.
Show Gene links
Show Anatomy links
A potent photoreactive general anesthetic with novel binding site selectivity for GABAA receptors.
Shalabi AR
,
Yu Z
,
Zhou X
,
Jounaidi Y
,
Chen H
,
Dai J
,
Kent DE
,
Feng HJ
,
Forman SA
,
Cohen JB
,
Bruzik KS
,
Miller KW
.
???displayArticle.abstract???
The pentameric γ-aminobutyric acid type A receptors (GABAARs) are the major inhibitory ligand-gated ion channels in the central nervous system. They mediate diverse physiological functions, mutations in them are associated with mental disorders and they are the target of many drugs such as general anesthetics, anxiolytics and anti-convulsants. The five subunits of synaptic GABAARs are arranged around a central pore in the order β-α-β-α-γ. In the outer third of the transmembrane domain (TMD) drugs may bind to five homologous intersubunit binding sites. Etomidate binds between the pair of β - α subunit interfaces (designated as β+/α-) and R-mTFD-MPAB binds to an α+/β- and an γ+/β- subunit interface (a β- selective ligand). Ligands that bind selectively to other homologous sites have not been characterized. We have synthesized a novel photolabel, (2,6-diisopropyl-4-(3-(trifluoromethyl)-3H-diazirin-3-yl)phenyl)methanol or pTFD-di-iPr-BnOH). It is a potent general anesthetic that positively modulates agonist and benzodiazepine binding. It enhances GABA-induced currents, shifting the GABA concentration-response curve to lower concentrations. Photolabeling-protection studies show that it has negligible affinity for the etomidate sites and high affinity for only one of the two R-mTFD-MPAB sites. Exploratory site-directed mutagenesis studies confirm the latter conclusions and hint that pTFD-di-iPr-BnOH may bind between the α+/β- and α+/γ- subunits in the TMD, making it an α+ ligand. The latter α+/γ- site has not previously been implicated in ligand binding. Thus, pTFD-di-iPr-BnOH is a promising new photolabel that may open up a new pharmacology for synaptic GABAARs.
???displayArticle.pubmedLink???
32247113
???displayArticle.pmcLink???PMC7342775 ???displayArticle.link???Eur J Med Chem ???displayArticle.grants???[+]
Bali,
Defining the propofol binding site location on the GABAA receptor.
2004, Pubmed,
Xenbase
Bali,
Defining the propofol binding site location on the GABAA receptor.
2004,
Pubmed
,
Xenbase
Belelli,
The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid.
1997,
Pubmed
,
Xenbase
Chiara,
Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.
2013,
Pubmed
Chiara,
Mapping general anesthetic binding site(s) in human α1β3 γ-aminobutyric acid type A receptors with [³H]TDBzl-etomidate, a photoreactive etomidate analogue.
2012,
Pubmed
Colton,
Depression of glutamate-mediated synaptic transmission by benzyl alcohol.
1977,
Pubmed
Crestani,
Contribution of the alpha1-GABA(A) receptor subtype to the pharmacological actions of benzodiazepine site inverse agonists.
2002,
Pubmed
Desai,
Gamma-amino butyric acid type A receptor mutations at beta2N265 alter etomidate efficacy while preserving basal and agonist-dependent activity.
2009,
Pubmed
,
Xenbase
Dostalova,
High-level expression and purification of Cys-loop ligand-gated ion channels in a tetracycline-inducible stable mammalian cell line: GABAA and serotonin receptors.
2010,
Pubmed
Dostalova,
Human α1β3γ2L gamma-aminobutyric acid type A receptors: High-level production and purification in a functional state.
2014,
Pubmed
Engin,
An Emerging Circuit Pharmacology of GABAA Receptors.
2018,
Pubmed
Forman,
Mapping General Anesthetic Sites in Heteromeric γ-Aminobutyric Acid Type A Receptors Reveals a Potential For Targeting Receptor Subtypes.
2016,
Pubmed
Hall,
m-Azipropofol (AziPm) a photoactive analogue of the intravenous general anesthetic propofol.
2010,
Pubmed
,
Xenbase
Hernandez,
A structural look at GABAA receptor mutations linked to epilepsy syndromes.
2019,
Pubmed
Husain,
2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels.
2003,
Pubmed
,
Xenbase
Iorio,
GABAA Receptor Ligands Often Interact with Binding Sites in the Transmembrane Domain and in the Extracellular Domain-Can the Promiscuity Code Be Cracked?
2020,
Pubmed
James,
Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents.
1980,
Pubmed
Jayakar,
Identifying Drugs that Bind Selectively to Intersubunit General Anesthetic Sites in the α1β3γ2 GABAAR Transmembrane Domain.
2019,
Pubmed
Jayakar,
Multiple propofol-binding sites in a γ-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog.
2014,
Pubmed
Kent,
Binding site location on GABAA receptors determines whether mixtures of intravenous general anaesthetics interact synergistically or additively in vivo.
2019,
Pubmed
,
Xenbase
Kita,
The partial molar volumes of anesthetics in lipid bilayers.
1981,
Pubmed
Krasowski,
General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility.
2001,
Pubmed
,
Xenbase
Laverty,
Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer.
2019,
Pubmed
Masiulis,
GABAA receptor signalling mechanisms revealed by structural pharmacology.
2019,
Pubmed
Nourmahnad,
Tryptophan and Cysteine Mutations in M1 Helices of α1β3γ2L γ-Aminobutyric Acid Type A Receptors Indicate Distinct Intersubunit Sites for Four Intravenous Anesthetics and One Orphan Site.
2016,
Pubmed
,
Xenbase
Olsen,
Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.
2015,
Pubmed
Olsen,
International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update.
2008,
Pubmed
Olsen,
GABA A receptors: subtypes provide diversity of function and pharmacology.
2009,
Pubmed
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Rudolph,
GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism.
2014,
Pubmed
Savechenkov,
Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.
2012,
Pubmed
Shanmugasundararaj,
The location and nature of general anesthetic binding sites on the active conformation of firefly luciferase; a time resolved photolabeling study.
2012,
Pubmed
Sieghart,
International Union of Basic and Clinical Pharmacology. CVI: GABAA Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans.
2018,
Pubmed
Siegwart,
Mutational analysis of molecular requirements for the actions of general anaesthetics at the gamma-aminobutyric acidA receptor subtype, alpha1beta2gamma2.
2003,
Pubmed
Stewart,
p-(4-Azipentyl)propofol: a potent photoreactive general anesthetic derivative of propofol.
2011,
Pubmed
,
Xenbase
Szabo,
Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant α1β3γ2L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites.
2019,
Pubmed
,
Xenbase
Whissell,
Altered expression of δGABAA receptors in health and disease.
2015,
Pubmed
Wu,
Inhibitable photolabeling by neurosteroid diazirine analog in the β3-Subunit of human hetereopentameric type A GABA receptors.
2019,
Pubmed
Yip,
A propofol binding site on mammalian GABAA receptors identified by photolabeling.
2013,
Pubmed
